AlphAIAlphAI — Financial news for AI agents
SEC EDGARAUG 72 min read$CL

CAHILL JOHN T sold $389K of CL

CAHILL JOHN T sold 4,170 shares of COLGATE PALMOLIVE CO (CL) at $93.37 ($0.39M total) on 2026-08-06.

Original reporting
SEC EDGAR · CAHILL JOHN T
Published Aug 7, 2026, 9:23 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 7, 2026, 9:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$CL
Neutral
medium confidence
Mentioned
$CL
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CLNeutralLow
01

Why it matters

The newest disclosed fact is the open-market sale of 4,170 shares at $93.3712 on 2026-08-06, with holdings after the sale of 28,373 shares.

02

Market read

Traders may note insider selling as a minor sentiment input, but there is no accompanying company-specific fundamental catalyst in the text.

03

What to watch

Insider sales can be driven by diversification, liquidity needs, or scheduled personal events; without context on prior holdings or compensation, signal strength is weak.

Relevance 4/10Novelty 3/10Timing: filed after-hours on 2026-08-07, covering a sale dated 2026-08-06

Background

The article is an SEC Form 4 insider transaction disclosure for Colgate Palmolive (CL) by director John T. Cahill.

Company-level read

Ticker impact

$CLNeutralMedium confidence
Context

Colgate Palmolive director John T. Cahill sold 4,170 shares in an open-market transaction worth about $389,358 on 2026-08-06.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven rather than fundamental.

Evidence & confidence

The filing is a Form 4 insider transaction, but the article provides no accompanying company news, guidance, or operational/regulatory catalyst.

Market effects

Sector

No clear sector read-through from a single director sale.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

The sale may be pre-planned or tax-related even if the filing states no 10b5-1 plan, so it may not reflect bearish fundamentals.

Key entities

  • issuer
    COLGATE PALMOLIVE CO

    Subject of the Form 4 insider sale disclosure.

  • insider
    CAHILL JOHN T

    Director who sold shares via open-market sale.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

CL insider trading history →

Related articles

OCT 9
High

Here's why Colgate-Palmolive shares jumped over 7% on Friday

Colgate-Palmolive (India) shares rose 8% after the GST Council recommended expanding input tax credit eligibility. The changes aim to reduce taxes and ease working-capital pressures. The company also benefited from a GST rate cut on oral-care products last year. Analysts estimate cost impacts from the inverted duty structure. The company reported strong revenue growth in Q1 FY27 and outlined growth strategies at an investor day.

cnbctv18.com2 min
SEP 28
$CLMedAI 8/10

Colgate-Palmolive (CL) is Making Room for Its Stronger Growth Engines. Will it Pay Off?

Colgate-Palmolive (CL) is considering selling mass-market personal care brands, including Softsoap and Speed Stick, for over $1 billion. The company aims to streamline its portfolio, focusing on higher-margin categories like Hill’s Pet Nutrition and international markets. Q2 2026 net sales rose 4.9% to $5.36 billion, with operating cash flow at $1.74 billion. Proceeds could reduce debt and optimize capital structure, but divestments may impact short-term revenue and earnings predictability.

insidermonkey.com2 min
SEP 21
$CLMed

Piper Sandler cuts Colgate-Palmolive stock price target on cost pressures

Piper Sandler reduced its price target for Colgate-Palmolive (CL) to $95 from $98, citing cost pressures from elevated oil prices and inventory headwinds. The firm maintained an Overweight rating and a 2026 EPS estimate of $3.85, but lowered its 2027 EPS estimate to $4.12 from $4.23. CL trades at $87.47 with a P/E ratio of 34.6 and a gross profit margin of 60%. Other analysts have maintained positive outlooks, with RBC and UBS setting higher price targets.

investing.com2 min
SEP 18
$CLMedAI 8/10

Colgate-Palmolive Explores Sale Of Softsoap, Irish Spring, Speed Stick Brands: Report

Colgate-Palmolive (CL) is exploring the sale of brands like Softsoap, Irish Spring, and Speed Stick, potentially fetching over $1 billion. The company is working with Goldman Sachs (GS) on the divestiture. Personal care accounted for 17% of CL's 2025 net sales, which totaled $20.38 billion. The move is part of a broader productivity and restructuring program aimed at generating annual pre-tax savings of $200 million to $300 million by 2028.

stocktwits.com2 min